Scooby and I are so excited to come back to our world of weight loss and obesity science, medication discussions, reviews and research.
Do you have any questions I haven’t answered yet? Or maybe you want to share an update?
Join me on YouTube, Instagram, Facebook or TikTok, and drop your questions, thoughts, stories, suggestions and ideas in the comments!
And don’t miss my first video back – join my mailing list now!
A new study has raised concerns about GLP-1s like Ozempic, Wegovy, and Mounjaro—but is the fear justified? I break down the real findings, the role of early detection bias, and what it actually means for GLP-1 users. Get the facts, not the fear.
Blurred vision after starting Ozempic, Wegovy, Mounjaro, or Zepbound? Discover the common reasons behind GLP-1-related vision changes, from blood sugar shifts to dehydration, and know when it’s time to speak to your doctor.
Wegovy and Zepbound are showing promise in treating heart failure, especially in individuals with obesity. Recent studies suggest that these medications could improve heart function, reduce inflammation, and help with weight management.
Switching from Wegovy to Zepbound doesn’t guarantee more weight loss. Wegovy targets GLP-1, while Zepbound works on both GLP-1 and GIP, which may offer additional benefits. But weight loss isn’t stackable—most people won’t lose more just by switching. I explain what to expect and who might benefit from the switch.
Calculate your daily calorie and protein targets to help you achieve your weight goals.
Calculate your daily calorie and protein targets to help you achieve your weight goals.
